Strength: 1 g per vial for IV or IM use
Form: Injectable (IV/IM)
Reference Brands: Invanz(US & EU)
Strength: 500 mg/500 mg, 1 g/1 g in vials
Form: Powder for Reconstitution
Reference Brands: Primaxin, Gemax (US & EU)
Strength: 500 mg/500 mg, 1 g/1 g per vial
Form: Intravenous (IV) Solutions
Strength: 500 mg, 1 g, 2 g in vials
Reference Brands: Merrem (US & EU), Merosan (india)
Strength: 500 mg, 1 g, 2 g per vial
Form: Intravenous (IV)
Reference Brands: Merrem (US & EU)
Strength: 0.5% or 1%
Form: Topical Creams and Ointments
Reference Brands: Neosporin(US & EU)
Strength: 1 g/2 mL, 2 g/2 mL
Reference Brands: Generic formulations marketed under different names
Strength: 300 mg/5 mL
Form: Inhalation Solution
Reference Brands: Bethkis, Tobi (US)
Strength: 10 mg/mL, 40 mg/mL, 80 mg/mL
Form: Injectable (IV, IM)
Strength: 25 mg/2 mL, 50 mg/2 mL
Reference Brands: Amikin(US)
Strength: 250 mg/2 mL, 500 mg/2 mL, 1 g/2 mL
Form: Injectable Solution
Reference Brands: Amikin(Us & EU)
Strength: 0.1% or 0.3%
Form: Cream
Reference Brands: Garamycin, Bramycin(US)
Strength: 40 mg/mL, 80 mg/mL, 80 mg/2 mL, 160 mg/2 mL
Strength: 50 mg/2 mL, 100 mg/2 mL, 50 mg/100 mL, 100 mg/100 mL
Form: Intravenous (IV) Solution
Reference Brands: Tygacil(US)
Strength: 100 mg/5 mL
Form: Intravenous
Reference Brands: Minocin(US)
Strength: 50 mg, 100 mg
Form: Tablets/Capsules
Strength: 250 mg, 500 mg
Form: Tablet/Capsules
Reference Brands: Sumycin(US), Tetra (India), Tetracyn (USA)
Strength: 20 mg/5 mL, 50 mg/5 mL, 100 mg/5 mL
Form: Suspension
Reference Brands: Vibramycin (US & EU), Doxicip (India)
Strength: 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 150 mg, 200 mg.5 Feb 2025
Form: Doxycycline Delayed-Release Tablets
Reference Brands: Vibramycin (US & EU)
Strength: 0.5%
Form: Ophthalmic Drops
Reference Brands: Zymaxid (US), Zymar (EU)
Stay updated on pharma trends and marketplace opportunities.